The tables below include useful information about all the different traditional herbal medicines which have been licensed by the Medicine and Healthcare products Regulatory Agency (MHRA) since the start of the transition to registered products in 2004.
The MHRA approved Summary of Product Characteristics (SPC) for every licensed medicine are available to view on their website. The SPC provides details of a medicine’s properties and the conditions for using it.
The SPCs form part of the Public Assessment Report (UKPAR) which the MHRA routinely publishes following licence approval. The approved carton label and Patient Information Leaflet (PIL) for each licensed medicine are included at the end of the document.
More information about the European Traditional Herbal Medicines Directive (EC/2004/24) is available on the MHRA website
Last updated: June 2015
Benign Prostatic Hypertrophy (BPH) | Cough/Cold/Flu | Varicose veins | Cystitis | Digestion | Low Mood | Menopause | Migraine relief | Anxiety | Premenstrual Syndrome (PMS) | Sleep | Slimming | Musculoskeletal | Raynaud’s Syndrome/Tinnitus | Urinary | Skin complaints | Teething
Benign Prostatic Hypertrophy (BPH)
| Product | Herb | THR Number | No. unit doses per day (Pack Size) | Suggested retail price* | Cost per day* | Max Daily herb equivalent | Shelf Life (months) | MHRA UK PAR |
|---|---|---|---|---|---|---|---|---|
| Prostasan capsules | Saw palmetto berries | 13668/0011 | One (30/60/90) | 30s £13.40, 90s £34.25 | 30s £0.45, 90s £0.38 | 3840 mg | 60 |  |